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Introduction
The concept of predicting future morbidity and mortality from 
cardiovascular diseases (CVDs) by measuring such factors 
as blood pressure (BP), body weight, or index of obesity and 
blood lipid originated in the life insurance industry during the 
1940’s and 1950’s[1] for individuals who sought and obtained 
life insurance. Hyperlipidemia, hypertension, and possibly 
obesity (all of which have long time recognized association 
with one another) appear to be the most important treatable 
factors that predispose patients to coronary heart disease. 
Coexistence of these factors is known to have multiplier effect 
with other CVD risk factors and has continued to translate to 
increasing CVD morbidity and mortality.
These noncommunicable diseases (NCDs) were some decades 
ago described as rare or low in blacks but more recent 
researches in Nigeria and other countries[2-17] indicate that 
their incidence in developing countries is gradually taking a 
prime position.
Bearing this changing trend in mind, continuous re-evaluation 
of these CVD risk factors cannot be over emphasized; more so, 
in different communities in developing nations where health 
indices still score below the standard. This regular assessment 
will re-evaluate data for these variables and emphasize the 
need for better education and provision of other appropriate 
early intervention measures at the grass root level. The positive 
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Background: Continuous re‑evaluation of modifiable cardiovascular risk factors (cardiovascular 
diseases [CVDs]) in developing nations is imperative as it lays foundation for early 
preventive/intervention measures at grass root level to improve/prevent CVD morbidity and 
mortality in those nations where health indices still score below the standard. Aim: The aim was 
to assess CVD risk factors as a continuous re‑evaluation of these may underscore the need for 
early intervention measures at grass root level. Subjects and Methods: A total of 257 apparently 
healthy inhabitants aged 18–85 years were recruited in a rural community in South Eastern 
Nigeria by convenient sampling. Blood pressure, waist circumference and blood lipid analysis 
were done procedurally and data analyzed using SPSS 16.0 statistical software. Results: The 
males were older (59.41 [5.22]) than the females (53.31 [16.90]). 69.2% (133/192) were low 
level farmers, retirees and dependents. Total cholesterol (TC), low density lipoprotein (LDL), 
and risk predictive index were higher in females while triglyceride (TG), high density lipoprotein 
and very LDL (VLDL) were higher in males. The middle aged and elderly respectively had higher 
TG and VLDL compared to the young. Aside hypertriglyceridemia, all lipid abnormalities were 
higher in females than males both singly (high TC: 28.9% [35/121] vs. 16.9% [12/71]; high 
LDL cholesterol: 52.0% [63/121] vs. 31.0% [22/71]) and in combination hypercholesterolemia 
with hypertriglyceridemia (42.9% [52/121] vs. 36.6% [26/71]). “Multiple risk factors” also 
occurred more in females with seeming further increase in older age. Conclusion: The chances 
of a female having CVD after menopause seemed to outweigh that of the male. CVD preventive 
measures should be focused at the primary/community level as a means to curtailing the 
increasing morbidity and eventual mortality from CVDs.
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impact of this may be quite enormous especially in a country 
like Nigeria where quacks and alternative health practitioners 
are readily available and render their services more or less 
unchecked. In this study, therefore, lipids and various CVD risk 
factors were assessed in a rural community in Southern Nigeria 
whose inhabitants are mainly of low socioeconomic class.
Subjects and Methods
The study was a cross-sectional community-based prevalence 
study carried out in August, 2011 in a homogenous 
(rural community) in Udi Local Government Area of Enugu State, 
Southeast Nigeria with a population of about 12,990 (projected 
at 15% increase every 5 years from 1991 census).
Before commencing the study, approval was obtained from 
the research and Ethics Committee of the Nnamdi Azikiwe 
University Teaching Hospital (NAUTH), Nnewi. Letters were 
written respectively to the traditional ruler and the town union 
of the community as well as to the local government authority 
and their written approval obtained. Informed consent was 
also obtained from each participant before being included in 
the study.
The sample size was calculated to be approximately 246 using 
the prevalence of multiple risk factors for coronary vascular 
disease as found in Ibadan, Nigeria which was 20%[18] using 
the standard formula. However, a total of 257 inhabitants of 
the community that participated in this study had their data 
analyzed.
All consenting apparently healthy subjects 18 years and above 
residing in the community were recruited into the study. All 
those with a history of current use of steroids, clinical evidence 
of fluid retention and all pregnant females were excluded 
from the study. Six medical officers were trained to help 
in this study along with two laboratory scientists. General 
physical examination was carried out on each participant who 
then had his/her waist circumference (WC) measured with 
a nonstretchable tape. The umbilicus was the landmark and 
where the abdomen was pendulous, the point in the abdomen 
with highest circumference was taken. WC ≥ 102 cm for males 
and ≥ 88 cm for females was regarded as abdominal obesity. 
Afterward, the participant got seated and a questionnaire 
detailing the individuals’ demographic and relevant family 
and social history was administered to each participant by a 
trained interviewer. This also afforded him/her opportunity to 
relax before the BP was checked.
Each participant’s BP was measured using the standard 
procedure. Three readings were taken at about 5–10 min 
interval and the mean of the last two was regarded as the 
subject’s BP. Hypertension was defined as BP ≥ 140/90 mmHg.
Ten milliliters of venous blood was withdrawn from willing 
participants who had not eaten into a container containing dry 
sodium ethylenediaminetetraacetic acid (1 mg/ml) mixed gently 
and separated and stored at − 20°C until analysis. The fasting 
period before sample collection was a minimum of 10 h since 
their last meal was at night and blood samples were collected 
before breakfast. Those who came after they had breakfast were 
asked to come the next day for collection of their fasting blood 
sample. Plasma total cholesterol (TC), high-density lipoprotein 
cholesterol (HDLC) and triglycerides (TGs) were done by 
colorimeter (enzymatic methods) in the chemical pathology 
laboratory of NAUTH, Nnewi using diagnostic sera kits by 
RANDOX Laboratories UK while low-density lipoprotein 
cholesterol (LDLC), and very LDLC (VLDLC) were calculated 
using the Friedewald Formula;[19] thus:
LDLC = TC - (HDLC + TG) mg / dl
5*
*2.2 if units were expressed in mmol/L
VLDLC = (Plasma TGs) mg/dl
5
or
VLDLC = (Plasma TGs) in mmol/L
2.2
The coronary heart disease risk predictive index was also 
calculated for each participant as LDLC/HDLC with value <2.1 
as desirable. For each batch of the assay, a commercial control 
serum of known value was always included and all the 
parameters were assayed within the same period in order to 
minimize inter and intra batch errors.
The NAUTH reference ranges were used in interpreting the 
lipid parameters. Hyperlipidemia was defined as raised plasma 
TC and/or raised plasma TG that is, TC > 5.17 mmol/L and 
or TG > 1.71 mmol/L (NAUTH reference ranges). Combined 
dyslipidemia was defined as TC > 5.17 mmol/L and or 
TG > 1.71 mmol/L plus low HDL. The lipid values for samples 
that were not properly labeled were all not included in the 
analysis. Lipid profile results were later sent to all participants 
who desired to have their cholesterol results sent to them.
Data analysis
The Microsoft Excel 2003 worksheet and  SPSS (16.0) 
statistical software  (manufacturer: SPSS Inc., 233 South 
Wacker Drive, 11th Floor, Chicago, IL 60606-6412. Patent 
No. 7,023,453) were used for data entry, validation, and 
analysis. Frequency distribution tables were formed from 
which percentages, mean values and standard deviations of the 
parameters studied were determined appropriately. Analysis 
of variance and Student’s t-test were used to look for gross 
differences in the parameters among groups of the subjects. 
P < 0.05 was taken as significant.
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Results
The occupations of the participants were farming 
(56.0% [144/257]), retirees/dependents (13.2% [34/257]), 
petty trading (7.8% [20/257]), Teaching/other paid 
jobs (9.3% [24/257]), artisans (7.4% [19/257]), and 
students (6.2% [16/257]). 27.6% (71/257) of the participants 
(27.5% [50/181]) of females and (14.5% [11/76]) 
o f  m a l e s ;  P  =  0 . 0 4 6  w e r e  o v e r w e i g h t  w h i l e 
12.8% (33/257) (16.0% [29/181] of females and 0.9% [7/76] 
of males; P = 0.26) were globally obese (body mass 
index ≥30 kg/m2).
Table 1 shows that the males were significantly older than 
the females (P < 0.01). The TC and LDL as well as the 
risk predictive index (RPI) were significantly higher in the 
females than in the males (P < 0.01, P = 0.02 and P = 0.03, 
respectively). TG, HDL, and VLDL were higher in the males 
than the females though not significantly (P = 0.54, 0.26 and 
0.92, respectively).
As shown in Table 2, apart from HDL which was either the same 
or slightly lower than the values of the other age groups, all the 
other lipid parameters and RPI were highest in the middle-aged 
subjects whereas HDL was highest in the elderly subjects. 
Except for TC, LDL, and RPI that were insignificantly higher 
in the young than in the elderly subjects, all the parameters 
were lowest in the young subjects. Age differed significantly 
among the three age groups and within pairs of the different 
age groups (P < 0.001). Between the young and the elderly, 
TG, VLDL, waist-to-hip ratio, and systolic BP (SBP) differed 
significantly (P = 0.02, P = 0.02, P < 0.001 and P < 0.001, 
respectively). Between the young and the middle-aged, TG 
as well as SBP and VLDL differed significantly (P = 0.03, 
P < 0.001, and P = 0.02, respectively). However, between the 
middle‑aged and the elderly, LDL and RPI were significantly 
different (respectively P = 0.05 and 0.04).
As Table 3 shows, the percentage of males who had 
hypertension (47.4% [36/76]) was higher than that of the 
females who had hypertension (41.4% [75/181]) though 
the difference was not statistically significant (P = 0.67 
abdominal obesity was significantly higher [P < 0.001]) 
among the females (38.1% [69/181]) than among the 
males (13.2% [10/76]). Compared to the males, females 
had higher prevalence of both hypercholesterolemia (high 
TC [P  =  0 .04]  and  h igh  LDL [P  =  0 .02]  and 
hypertriglyceridemia [P = 0.41]) as single entities (high TC: 
52/181 28.7% vs. 13/7617.1%; P = 0.04 , High LDLC: 
51.9% [94/181] vs. 31.6% [24/76]; P = 0.02) as well as in 
combination (hypercholesterolemia ± hypertriglyceridemia: 
43.1% [78/181] vs. 36.8% [28/76]; [P = 0.19]). Combined 
dyslipidemia (hypercholesterolemia ± hypertriglyceridemia 
and low HDL) was also more prevalent among the 
females (42.0% [76/181] vs. 34.2% [26/76]; P = 0.37).
Among the subjects that had only one risk factor, there were 
more males (39.5% [30/76]) than females (34.3% [62/181]). 
Conversely, for those who had two or more risk factors, there were 
more females (30.9% [56/181]) than males (21.1% [16/76]). 
Table 1: Distribution and comparison of age, BP, lipid, and 








Age (years) 59.4 (15.22) 53.31 (16.90) 55.14 (16.63) <0.01*
TG (mmol/L) 1.22 (0.89) 1.18 (0.9) 1.20 (0.89) 0.54
TC (mmol/L) 3.17 (1.59) 3.75 (1.45) 3.58 (1.51) <0.01*
HDL (mmol/L) 0.39 (0.27) 0.36 (0.22) 0.37 (0.23) 0.26
VLDL (mmol/L) 0.56 (0.38) 0.54 (0.42) 0.54 (0.41) 0.92
LDL (mmol/L) 2.23 (1.52) 2.85 (1.39) 2.67 (1.45) 0.02*
RPI 8.00 (7.43) 10.41 (7.31) 9.72 (7.41) 0.03*
BMI (kg/m2) 24.6 (3.9) 24.9 (5.1) 24.8 (4.8) 0.21
WHR 0.99 (0.07) 0.95 (0.10) 0.96 (0.96) <0.01
SBP (mmHg) 140.29 (31.15) 137.28 (25.96) 137.80 (27.26) 0.84
DBP (mmHg) 77.46 (16.32) 79.23 (14.02) 78.68 (16.62) 0.64
Values expressed as means (SD). n: Number of subjects. *Level of statistical significance 
at <0.05. SD: Standard deviation, BP: Blood pressure, TG: Triglyceride, HDL: High‑density 
lipoprotein, LDL: Low density lipoprotein, VLDL: Very low density lipoprotein, TC: Total 
cholesterol, RPI: Rice protein isolate, BMI: Body mass index, WHR: Waist-to-hip ratio, 
SBP: Systolic blood pressure, DBP: Diastolic blood pressure
Table 2: Distribution and comparison of the parameters among the different age groups















Age (years) 30.25 (8.71) 54.4 (5.72) 72.28 (5.85) <0.001** <0.001** <0.001** <0.001**
TG (mmol/L) 0.93 (0.82) 1.26 (0.84) 1.20 (0.89) 0.04 0.02* 0.03* 0.58
TC (mmol/L) 3.41 (1.50) 3.83 (1.56) 3.37 (1.41) 0.17 0.12 0.83 0.08
HDL (mmol/L) 0.35 (0.23) 0.36 (0.25) 0.38 (0.22) 0.75 0.45 0.52 0.95
VLDL (mmol/L) 0.42 (0.37) 0.57 (0.38) 0.54 (0.45) 0.04 0.02* 0.03 0.59
LDL (mmol/L) 2.64 1.47) 2.89 (1.52) 2.40 (1.32) 0.13 0.07 0.66 0.05*
RPI 9.86 (7.08) 10.80 (8.29) 8.19 (6.08) 0.06 0.03* 0.75 0.04*
SBP (mmHg) 126.22 (20.99) 139.81 (29.08) 145.21 (27.21) 0.001* <0,001* 0.01* 0.22
DBP (mmHg) 91.33 (18.23) 81.46 (15.67) 78.99 (14.03) 0.48 0.37* 0.42 0.29
WHR 0.66 (0.34) 0.77 (0.31) 0.79 (0.24) 0.3* <0.01* 0.03* 0.10
Values expressed as means (SD). n: Number of subjects. *Level of statistical significance at <0.05, **Level of statistical significance at<0.001. SD: Standard deviation, BP: Blood pressure, 
TG: Triglyceride, HDL: High density lipoprotein, LDL: Low density lipoprotein, VLDL: Very low density lipoprotein, TC: Total cholesterol, RPI: Rice protein isolate, WHR: Waist‑to‑hip ratio, 
SBP: Systolic blood pressure, DBP: Diastolic blood pressure, ANOVA: Analysis of variance
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The differences were, however, not significant (P = 0.20) as 
shown in Table 4a.
Those 55 years and above had higher prevalence of 
“two or more” risk factors (30.7% [42/137]) compared 
to those <55 years (25.0% [32/120]; P = 0.37). For 
those <55 years, the prevalence of “only one” risk factor was 
higher in males than the females but “two or more risk factors” 
was more prevalent in females than the males. However, in 
those 55 years and above, females had a higher prevalence of 
both “only one” and “two or more” risk factors [Table 4b].
Table 5 shows the number of risk factors in the young, 
middle aged and elderly subjects. Among the three age 
groups, the elderly subject had highest prevalence of “only 
one” risk factor followed by the young and then the middle 
aged subjects. The variations in the prevalence showed no 
statistical significance (P = 0.53 and 0.53, respectively). 
However, among the subjects that had “two or more” risk 
factors, the prevalence was highest in the middle aged 
subjects compared to the other age groups and this difference 
was significant between the middle aged and the young 
subjects (P = 0.05).
As Table 6 shows, the hypertensive subjects were significantly 
older than the nonhypertensive subjects (P < 0.01). All the 
lipid parameters with the exception of HDL were higher in 
the hypertensive subjects than in nonhypertensive subjects.
As shown in Table 7, the percentages of those with abdominal 
obesity who had high BP (HBP) (58.2% [46/79]) differed 
significantly (P = 0.04) when compared with 36.5% (65/178) 
who had HBP among those with normal WC. The prevalence 
of hypercholesterolemia among those with abdominal obesity 
was significantly higher than among those with normal 
WC (41.8% [33/79] vs. 18.0% [32/178]; P = 0.03).
Subjects with HBP had higher prevalence of both 
hypercholesterolemia (27.9% [31/111]) and combined 
dyslipidemia (41.4% [46/111]) compared to those with 
normal BP who had high TC (23.3% [34/146]) and combined 
dyslipidemia (38.4% [56/146]); the difference between 
these prevalence values was, however, not statistically 
significant (P = 0.27 and 0.14, respectively). Those 
with combined dyslipidemia had higher prevalence of 
hypertension (45.1% [46/102] vs. 41.3% [65/155]) and 
abdominal obesity (36.3% [37/102] vs. 27.1% [42/15]) 
compared to those without dyslipidemia.
Discussion
The mean values of the atherogenic lipids were similar to 
the finding in many other recent studies[9,14-17] in being lower 
than the upper limits just as the mean HDL value was lower 
than the desirable minimum. When compared with those 
previous local studies, the values obtained in this study were 
generally much lower. This may be because even when the 
participants had similar age brackets, most of those previous 
studies were done in settings and socioeconomic classes that 
were mixed or different from this one. The participants in this 
study were mostly low-level famers, petty trades, and elderly 
dependents. Thus, as serum lipids are known to be influenced 
by nutrition, the lower mean lipid values obtained in this study 
may suggest that the inhabitants of this community had poor/
poorer nutrition.
Some previous researchers[8-10,12,14,15] observed higher values of 
TG in males than females just as found in this study. However, 
contrary to some of these studies[10] and in agreement with 
others,[9,14] the difference in mean TG value in both sexes was 
Table 3: Prevalence of HBP, abdominal obesity, and lipid abnormalities in relation to gender
Risk factors All subjects (n=257) (%) Males (n=76) (%) Females (n=181) (%) P
Mean age (years) 55.14 (16.63) 59.49 (15.22) 53.31 (16.90) <0.01*
HBP 111 (43.2) 36 (47.4) 75 (41.4) 0.67
Abdominal obesity 79 (30.7) 10 (13.2) 69 (38.1) <0.001*
Hypertriglyceridemia 63 (24.5) 20 (26.3) 43 (23.8) 0.28
Hypercholesterolemia (high TC) 65 (25.3) 13 (17.1) 52 (28.7) 0.04*
High LDLC 118 (45.9) 24 (31.6) 94 (51.9) 0.02*
Hypercholesterolemia ± hypertriglyceridemia 106 (41.4) 28 (36.8) 78 (43.1) 0.19
Low HDLC 248 (96.5) 71 (93.4) 177 (97.8) 0.27
Combined dyslipidemia (hypercholesterolemia ± 
hypertriglyceridemia and low HDL)
102 (39.7) 26 (34.2) 76 (42.0) 0.37
CVD RPI 234 (91.1) 62 (81.6) 172 (95.0) 0.27
HBP=BP ≥140/90 mmHg. Abdominal obesity=WC ≥102 cm (males) or 88 cm (females), hyperlipidemia=TG >1.71 mmol/L and/or TC >5.17 mmol/L, combined dyslipidemia=TG >1.71 mmol/L 
and/or TC >5.17 mmol/L plus low HDL, RPI=LDL/HDL ≥2.1. n: Number of subjects. HDL: High‑density lipoprotein, LDL: Low density lipoprotein, RPI: Rice protein isolate, TG: Triglyceride, 
TC: Total cholesterol, HBP: High blood pressure, CVD: Cardiovascular diseases, WC: Waist circumference, LDLC: Low density lipoprotein cholesterol, HDLC: High density lipoprotein 
cholesterol, BP: Blood pressure
Table 4a: Number of risk factors according to gender










Only one risk factor 92 (35.8) 30 (39.5) 62 (34.3) 0.17
Two or more risk factors 72 (28.0) 16 (21.1) 56 (30.9) 0.20
Total 257 (100) 76 (29.6) 181 (70.4)
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not statistically significant. Again, contrary to the finding of 
a recent study of elderly subjects in south-east Nigeria,[14] 
in which males had higher values of all lipids parameters 
measured, the females in this study had significantly higher 
TC and LDL values (P < 0.01 and P = 0.02, respectively) than 
their male counterparts. The observed sex variation in respect 
of lipid in this and the other study may be accounted for by the 
differences in the diets of the two different study populations. 
The findings in this study, however, agrees with the finding of 
the Nigeria National NCD survey report on cholesterol values 
in adult males and females.[20]
Whereas older studies observed that serum lipid concentration 
did not alter with age in underprivileged Africans after 
adulthood,[21] more recent studies[14] found an age-related trend 
in serum lipid concentrations. This study, however, showed no 
consistent trend. This inconsistent trend supports the finding 
by Miller[22] in which LDL values showed no consistent trend 
with age and just like in this study, the 45–64 years age group in 
their study had the highest values of the parameters measured. 
The finding of lowest concentration of TC in the elderly 
(above 65 years) subjects of this study may not necessarily 
be a contradiction or concordance of earlier studies[23] 
Table 4b: Number of risk factors in those below and above 55 years in relation to gender
Number of 
risk factors























12 (54.5) 31 (31.6) 43 (35.8) 18 (33.3) 31 (37.3) 49 (35.8) 0.19 0.03* 0.41
Two or more 
risk factors
3 (13.6) 27 (27.6) 30 (25.0) 13 (24.1) 29 (34.9) 43 (30.7) 0.37 43 0.79
*Level of statistical significance at <0.05. ANOVA: Analysis of variance
Table 5: Number of risk factors in the young, middle aged and elderly subjects















Age (years) 30.25 (8.71) 54.4 (5.72) 72.28 (5.85) <0.001* <0.001* <0.001* <0.001*
Only one risk factor 20 (35.5) 39 (33.9) 33 (38.4) 0.53 0.26 0.17 0.83
Two or more risk factors 9 (16.1) 39 (33.9) 24 (27.9) 0.53 0.14 0.05* 0.70
*Level of statistical significance at <0.05, **Level of statistical significance at <0.001. ANOVA: Analysis of variance
Table 6: Comparison of the parameters between hypertensive (BP ≥140/90 mmHg) and nonhypertensive subjects
Parameters Hypertensive subjects (n=111) Nonhypertensive subjects (n=146) Total (n=257) P
Age (years) 58.69 (12.73) 52.30 (18.74) 55.04 (16.70) ≤0.01*
TG (mmol/L) 1.34 (0.95), n=88 1.10 (0.84), n=111 1.21 (0.90), n=199 0.09
TC (mmol/L) 3.76 (1.63) 3.43 (1.40) 3.58 (1.51) 0.37
HDL (mmol/L) 0.36 (0.23) 0.37 (0.24) 0.36 (0.23) 0.18
VLDL (mmol/L) 0.61 (0.43) 0.50 (0.38) 0.55 (0.41) 0.42
LDL (mmol/L) 2.80 (1.56) 2.56 (1.36) 2.67 (1.45) 0.43
RPI 10.56 (8.15) 9.14 (6.84) 9.77 (7.46) 0.84
Values expressed as means (SD). n: Number of subjects. *Level of statistical significance at <0.05, **Level of statistical significance at <0.001. SD: Standard deviation, BP: Blood pressure, 
TG: Triglyceride, HDL: High density lipoprotein, LDL: Low density lipoprotein, VLDL: Very low density lipoprotein, TC: Total cholesterol, RPI: Rice protein isolate
Table 7: Relationship between the various risk factors
Risk factors Abdominal obesity (%) (n=79) Normal WC (%) (n=178) Total (%) (n=257) P
HBP 46 (58.2) 65 (36.5) 111 (43.2) 0.04*
Hypercholesterolemia 33 (41.8) 32 (18.0) 65 (25.3) 0.03*
HBP (%) (n=111) Normal BP (%) (n=146)
Hypercholesterolemia 31 (27.9) 34 (23.3) 65 (25.3) 0.27
Combined dyslipidemia 46 (41.4) 56 (38.4) 102 (39.7) 0.14
Dyslipidemia (%) (n=102) Normolipidemia (%) (n=155)
HBP 46 (45.1) 65 (41.3) 111 (43.2) 0.14
Abdominal obesity 37 (36.3) 42 (27.1) 79 (30.7) 0.73
*Level of statistical significance at <0.05. Hypercholesterolemia=TC >5.17 mmol/L. TC: Total cholesterol, HBP: High blood pressure, WC: Waist circumference, BP: Blood pressure
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(in which TC did not necessarily rise with age but TG did) 
since those earlier studies involved only young and middle age 
(45–65 years) subjects and thus did not compare the TC values 
in older age groups as done in this present study. Except for 
HDL which rose steadily with age, all the other lipid parameters 
rose from young to middle age and then dropped in the elderly. 
This observed age-related variation in lipid level in this study 
has been demonstrated in different European communities 
which found that lipid parameters attained peak values at 
about 50 years after which the values began to fall.[14,24] All 
the atherogenic risk factors as well as RPI (i.e., LDL/HDL) 
were more favorable in those who were normotensive and/or 
“not obese” than in those who had either of these and this is in 
keeping with other studies[11,25] that reported direct association 
between lipid levels and LDL/HDL ratio.
The general prevalence of HBP documented in this study 
was 43.2% (males: 47.4%, females: 41.4%) while abdominal 
obesity prevalence was 30.7% (males: 13.2%, females: 
38.1%). Those with abdominal obesity had significantly higher 
prevalence of HBP (58.2% vs. 36.5%; P = 0.04) and high 
TC (41.8% vs. 18.0%; P = 0.03) than those without abdominal 
obesity; an association that has long been established.[2-6,26,27] 
Those with combined dyslipidemia also had a higher 
prevalence of both HBP (45.1% vs. 41.3%) and abdominal 
obesity (36.3% vs. 27.1%) than those with normolipidemia, as 
documented in other studies.[8,9,26,28] In agreement with previous 
studies which demonstrated high dyslipidemia prevalence in 
hypertensive patients in Nigeria, mean values of all atherogenic 
lipids were higher in those found to have hypertension in this 
study compared to normotensive subjects. Mean HDL value in 
this study was similar in those with HBP (0.36 [0.23] mmol/L) 
and in nonhypertensive subjects (0.37 [0.24] mmol/L) thus, 
collaborating the finding by some researchers that aside 
HDL every other cardiovascular co-morbidity was higher in 
hypertensives.[26]
In this study, 35.8% of the participants (males: 39.5%, females: 
34.3%); (P = 0.17) had “only one” of the three cardiovascular 
risk factors assessed while 28.0% (males: 21.1%, females: 
30.9%) had “two or more” risk factors. This finding is higher 
than the prevalence of multiple risk factors for coronary 
vascular disease as found over a decade ago in a rural 
community in Ibadan, Western Nigeria[18] which was 20% and 
even a more recent study which found prevalence of at least 
one CVD risk factor to 12.9%. Despite some sociocultural 
differences between that rural community and this one, 
our findings suggest that coronary vascular risk factors are 
not just increasing in Nigerians as single entities but in 
groups/multiples.
The prevalence of elevated serum TC was 25.3% (males: 17.1%, 
females: 28.7%), elevated LDLC was 45.9% (males: 31.6%, 
females: 51.9%) while that of combined hyperlipidemia (high 
TC and/or high TG level) was 39.7% (males; 34.2%, females; 
42.0%). These prevalence values for high TC and high LDL 
varied with findings by other researchers in Nigeria[8,9,14,16,28] 
and some other developing nations;[12,13] being lower in some 
and higher in others. This difference may be accounted for 
by the fact that those other studies were conducted in settings 
different from that in which this study was conducted in that 
those ones were either hospital-based or involved people of 
different or mixed socioeconomic class unlike the case in our 
study.
Low HDL prevalence in this study was as high as 96.5% while 
combined dyslipidemia was 39.7%; both being higher than 
previous research findings in Nigerians[8,9,14,15,28] and some Asian 
countries.[29] On the same note, hypertriglyceridemia prevalence 
was higher in this study (24.5%) compared to previous research 
findings in different parts of Nigeria[8,9,15,26,28,30] and South 
Asia[29] but lower than the finding in one study in Iran.[12] It is, 
however, similar to the finding in a Lagos; commercial city 
in Nigeria[8] and in a South African study.[13] Contrary to high 
LDL which was said to be the most common lipid abnormality 
followed by LDL, this study found the reverse with low HDL 
being the most common lipid abnormality before LDL. This 
opposite finding may be because that was a review study[8] 
which include studies done in healthy people as well as 
those done on patients. The finding of low HDL as the most 
prevalent lipid abnormality has been demonstrated in other 
community-based studies.[9,15,28-30] Hypertriglyceridemia was 
also the least occurring lipid abnormality as found in some 
other study, though hospital based.[31] In relation to gender, the 
females had higher prevalence of high TC (28.7% vs. 17.1%; 
P < 0.05) and low HDL (97.8% vs. 93.3%) as found in other 
studies[9,12,15] but contrary to some studies[31] and in agreement 
with some,[29] the higher low HDL prevalence in females 
showed no statistical significance compared to the males; 
P > 0.05. Unlike in one of those studies,[9] this study found that 
the prevalence of high LDL was still higher in females (51.9% 
vs. 31.6%; P < 0.05) like in some others.[15]
In the general population, the prevalence of “only one 
risk factor” in this study was the same both above and 
below 55 years, whereas “two or more risk factors” was 
more prevalent above 55 years. Furthermore, the middle 
aged subjects had highest prevalence of “two or more risk 
factors” (33.9%) compared to the elderly (27.9%; P = 0.70), 
and then the young who had the least prevalence (16.1%; 
P = 0.05). It, therefore, seemed that the prevalence of multiple 
risk factors increased with age and then began to drop after the 
middle age in this community; a trend which recent studies 
have demonstrated for individual CVDs in Nigerians.[2,32]
As can be seen in Table 3, aside hypertriglyceridemia, the 
females had higher prevalence of all other lipid abnormality 
compared to the males and as shown in Table 4a and b, they 
also had higher prevalence of multiple risk factors both in 
the general population and above and below 55 years age 
groups. A study conducted about a decade ago in Nigerians[3] 
indicated that gender was not a modifier of cardiovascular risk 
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in Nigeria. Our data tend to suggest that CVD risk prevalence 
was higher in females and the degree of risk in them tended 
to increase further in older age when all the risk factors were 
considered either singly (“only one risk factor”) or collectively 
(“two or more risk factors”). These findings suggest that the 
females in this study (mean age: 53.1 years) seemed to run 
higher risk of CVD than the males who were significantly 
older (mean age: 59.4 years; P < 0.01).
Limitations of study
Due to financial constraint and other logistics, contact with 
each participant was once. Those with grade 1 hypertension 
should have had follow‑up checks but this first time and only 
visit was taken as their BP as in other epidemiologic studies.
Conclusion
Cardiovascular disease risk factors are prevalent even in rural 
communities in Southeast Nigeria and the chances of a female 
having CVD after menopause seemed to outweigh that of 
the age-matched male. There is a need for health education 
at the primary/community level as a means to curtailing the 
increasing morbidity and eventual mortality from CVDs.
Recommendation
Periodic screening of individuals at risk by clinicians and other 
health workers using the parameters studied in this research 
work is advocated. Education and lifestyle modification are 
important measures to be deployed by responsible health 
professionals in addressing the rising trend of CVDs in Nigeria 
and nations with similar setting.
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